Company intelligence / Profile preview

Dictum Health

Oakland, California, United Statessuntechmed.com ↗

Ownership: Private
Employees: ~21
Development stage: Commercial

Overview

Dictum Health has developed FDA-cleared telehealth solutions including the VER platform and IDM100 tablet. These are used for remote clinical exams with real-time vital sign streaming. Clinical studies have shown positive trends in reducing readmissions, improving outcomes, and lowering costs—such as a neonatal cardiac program at UC Davis Medical Center. The company’s products are deployed across hospitals for remote patient monitoring.

Therapeutic areas: OtherCardiovascular
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

JACS SolutionsSunTech MedicalCreekridge Capital

Beyond the preview

Go deeper on Dictum Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dictum Health.

Explore the full profile